Bifidobacterium breve MAK40B22B and Reduced Inflammatory Markers

• Oral administration of Bifidobacterium breve B-3 modifies metabolic functions in adults with obese tendencies in a randomised controlled trial

  • 2015-06-19
  • RCT
  • Journal of Nutritional Science 4
  • • J. Minami
    • S. Kondo
    • N. Yanagisawa
    • T. Odamaki
    • J. Xiao
    • F. Abe
    • S. Nakajima
    • Yukie Hamamoto
    • Sanae Saitoh
    • T. Shimoda

  • PubMed: 26090097
  • DOI: 10.1017/jns.2015.5

  7 Insights on

  • Reduced Inflammatory Markers

  • High evidence
  • Highly Cited

  Improvements were observed for some blood parameters related to liver functions and inflammation, such as high-sensitivity C-reactive protein.

  Effect

  Beneficial

  Effect size

  Small